| Literature DB >> 35435752 |
Adéla Finstrlová1, Ivana Mašlaňová1, Bob G Blasdel Reuter2, Jiří Doškař1, Friedrich Götz3, Roman Pantůček1.
Abstract
Kayviruses are polyvalent broad host range staphylococcal phages with a potential to combat staphylococcal infections. However, the implementation of rational phage therapy in medicine requires a thorough understanding of the interactions between bacteriophages and pathogens at omics level. To evaluate the effect of a phage used in therapy on its host bacterium, we performed differential transcriptomic analysis by RNA-Seq from bacteriophage K of genus Kayvirus infecting two Staphylococcus aureus strains, prophage-less strain SH1000 and quadruple lysogenic strain Newman. The temporal transcriptional profile of phage K was comparable in both strains except for a few loci encoding hypothetical proteins. Stranded sequencing revealed transcription of phage noncoding RNAs that may play a role in the regulation of phage and host gene expression. The transcriptional response of S. aureus to phage K infection resembles a general stress response with differential expression of genes involved in a DNA damage response. The host transcriptional changes involved upregulation of nucleotide, amino acid and energy synthesis and transporter genes and downregulation of host transcription factors. The interaction of phage K with variable genetic elements of the host showed slight upregulation of gene expression of prophage integrases and antirepressors. The virulence genes involved in adhesion and immune evasion were only marginally affected, making phage K suitable for therapy. IMPORTANCE Bacterium Staphylococcus aureus is a common human and veterinary pathogen that causes mild to life-threatening infections. As strains of S. aureus are becoming increasingly resistant to multiple antibiotics, the need to search for new therapeutics is urgent. A promising alternative to antibiotic treatment of staphylococcal infections is a phage therapy using lytic phages from the genus Kayvirus. Here, we present a comprehensive view on the phage-bacterium interactions on transcriptomic level that improves the knowledge of molecular mechanisms underlying the Kayvirus lytic action. The results will ensure safer usage of the phage therapeutics and may also serve as a basis for the development of new antibacterial strategies.Entities:
Keywords: Kayvirus; RNA-Seq; Staphylococcus aureus; Staphylococcus phages; bacteriophage therapy; noncoding RNA; phage-host interactions; prophages; transcriptome; viral transcription
Mesh:
Year: 2022 PMID: 35435752 PMCID: PMC9241854 DOI: 10.1128/spectrum.00123-22
Source DB: PubMed Journal: Microbiol Spectr ISSN: 2165-0497
FIG 1Phage K transcription analysis. (A) Normalized phage gene expression profile. Each line represents a gene. (B) Heatmap of phage log2-transformed normalized counts per gene generated using DESeq2. Clustering of phage genes by their expression divides the genes into three groups – early, middle, and late. (C) Transcriptional profile of phage K genome from plus and minus DNA strand in two S. aureus strains, Newman and SH1000. The genetic map of the phage genome is indicated by arrows showing the direction of transcription and the genome modules with known functions are depicted with color boxes bellow the ORF map. The depicted long terminal repeat (LTR) has aligned reads from both phage LTRs. The genes in panels A, B, and C are colored based on their transcription phase in the same way as in section (A). (D) Comparison of phage K gene expression in S. aureus SH1000 versus Newman. Each line represents relative expression in the analyzed sampling time points. Gene product numbers (gp) were obtained from previously published phage K genome (18).
Noncoding RNA species in phage K genome
| Name | Genome position | Strand | Location with reference to other genes | Possible targets phage K | Possible targets |
|---|---|---|---|---|---|
| lnc001 | 13595-14229 | Minus | Intergenic region gt001 and gp032 | n.a. | n.a. |
| lnc002 | 37679-38832 | Minus | Intergenic region gp191 and gt004 | n.a. | n.a. |
| snc001 | 3114-3628 | Plus | Antisense gp009 | 41488-41509 between genes gp184 and gp185 | NWMN_RS07005 threonine synthase, |
| snc002 | 5022-5067 | Minus | Intergenic region gp012 and gp013 | n.a. | NWMN_RS13395 hypothetical protein |
| snc003 | 6186-6352 | Plus | Intergenic region gp015 and gp016 | 39055-39071 plus strand upstream of 5′ end gp191 | NWMN_RS15600 hypothetical protein |
| snc004 | 8370-8665 | Minus | Intergenic region gp021 and gp022 | n.a | NWMN_RS01765 NWMN_RS10130 |
| snc005 | 40560-40861 | Plus | Antisense to 5‘ end of gp186 | 9061-9122 overlap of genes gp023 and gp024 | NWMN_RS06190 phospho-N-acetylmuramoyl-pentapeptide- transferase |
| snc006 | 119140-119325 | Plus | Intergenic region gp104 and gp105 | 35440-35476 in intron gp194 | NWMN_RS14275 fructosamine kinase family protein |
| snc007 | 127601-127826 | Plus | Intergenic region gp084 and gp085 | 15355-15429 upstream of stop codon gp231 | NWMN_RS07550 virulence factor C |
For small ncRNA, one possible RNA target in the phage K genome (GenBank accession number NC_005880.2), and the three RNA targets with the highest interaction energy in the S. aureus Newman genome are listed. n.a., not available, no target was found.
Differentially expressed bacterial genes: selected annotated genes of two S. aureus strains, Newman and SH1000, that are significantly up- or downregulated during phage K infection compared to uninfected control based on RNA-Seq data
| Fold change | |||||
|---|---|---|---|---|---|
| Gene | Newman | SH1000 | |||
| (RefSeq gene ID) | Function, protein | 10 min | 20 min | 10 min | 20 min |
| Regulators | |||||
| NWMN_RS11225 | Accessory gene regulator AgrA | n.s. | 0.51 | n.s. | n.s. |
| NWMN_RS11220 | Accessory gene regulator AgrC | n.s. | 0.65 | n.s. | n.s. |
| NWMN_RS11395 | RNA polymerase sigma factor SigB | 1.94 | 1.58 | 1.65 | n.s. |
| NWMN_RS07470 | Response regulator transcription factor ArlR | 2.18 | n.s. | 1.99 | n.s. |
| NWMN_RS07465 | Sensor histidine kinase ArlS | 1.95 | n.s. | 2.11 | n.s. |
| NWMN_RS08890 | Sensor protein kinase WalK | 1.97 | n.s. | 1.57 | n.s. |
| NWMN_RS03715 | Transcriptional regulator MgrA | 0.46 | 0.48 | n.s. | n.s. |
| Stress response | |||||
| NWMN_RS14920 | Cold-shock protein CspG | 0.14 | 0.14 | 0.18 | 0.28 |
| NWMN_RS04305 | Cold-shock protein CspC | 0.20 | 0.19 | 0.21 | 0.31 |
| NWMN_RS13180 | Oxygen regulatory protein NreC | 5.28 | n.s. | n.s. | n.s. |
| NWMN_RS13185 | Oxygen sensor histidine kinase NreB | 3.23 | 3.00 | n.s. | n.s. |
| NWMN_RS05970 | Thioredoxin TrxA | n.s | 0.59 | n.s. | n.s. |
| NWMN_RS03810 | Glycosyltransferase CsbB | 3.15 | n.s. | n.s. | n.s. |
| NWMN_RS07065 | SOS-response protein LexA | 0.48 | n.s. | 0.58 | n.s. |
| NWMN_RS03125 | Uracil-DNA glycosylase Ung | 0.62 | n.s. | n.s. | n.s. |
| Pathogenesis | |||||
| NWMN_RS06080 | Alpha hemolysin Hly | 1.76 | 2.12 | n.s. | 9.24 |
| NWMN_RS13355 | Gamma-hemolysin HlgAB/HlgCB subunit | 2.63 | 3.80 | n.s. | 4.63 |
| NWMN_RS13345 | Gamma-hemolysin HlgAB subunit A | 3.56 | 3.80 | n.s. | n.s. |
| NWMN_RS13335 | Immunoglobulin-binding protein Sbi | n.s. | 3.03 | n.s. | 5.41 |
| NWMN_RS13795 | Fibronectin-binding protein FnbB | n.s. | 3.24 | n.s. | n.s. |
| NWMN_RS04280 | MSCRAMM family adhesin clumping factor ClfA | 3.93 | 3.06 | n.s. | n.s. |
| NWMN_RS10800 | Chemotaxis inhibiting protein Chp | n.s. | 0.53 | - | - |
| Nucleotide biosynthesis pathway | |||||
| NWMN_RS00455 | Purine nucleoside phosphorylase DeoD | 6.63 | 5.33 | 4.68 | 10.09 |
| NWMN_RS00085 | Adenylosuccinate synthetase PurA | 2.00 | 1.85 | 1.75 ( | 2.21 |
| NWMN_RS07050 | GMP reductase GuaC | 2.42 | 2.18 | 4.19 | 3.69 |
| Nitrogen cycle metabolic process | |||||
| NWMN_RS13190 | GAF domain-containing protein | 4.45 | 4.65 | n.s. | n.s. |
| NWMN_RS13195 | Respiratory nitrate reductase subunit gamma NarI | 4.34 | 4.16 | n.s. | n.s. |
| NWMN_RS13200 | Nitrate reductase molybdenum cofactor assembly NarJ | 5.68 | 4.96 | n.s. | n.s. |
| NWMN_RS13205 | Nitrate reductase subunit beta NarH | 6.04 | 5.60 | n.s. | n.s. |
| NWMN_RS13210 | Nitrate reductase subunit alpha NarG | 6.64 | 6.26 | n.s. | n.s. |
| NWMN_RS13215 | Uroporphyrinogen-III C-methyltransferase CobA | 6.99 | 5.80 | n.s. | n.s. |
| NWMN_RS13220 | Nitrite reductase small subunit NirD | 9.74 | 4.93 | n.s. | n.s. |
| NWMN_RS13225 | NAD(P)/FAD-dependent oxidoreductase NasD | 26.63 | 13.53 | n.s. | n.s. |
| NWMN_RS13230 | Sirohydrochlorin chelatase SirB | 22.27 | 10.99 | n.s. | n.s. |
| Amino acid metabolism | |||||
| NWMN_RS04695 | Argininosuccinate synthase ArgG | 2.71 | 3.37 | n.s. | n.s. |
| NWMN_RS06110 | Ornithine carbamoyltransferase ArgF | 4.63 | 3.67 | 3.36 ( | 20.68 |
| NWMN_RS06115 | Carbamate kinase ArcC1 | 2.40 | 2.79 | 3.77 | 20.56 |
| NWMN_RS07005 | Threonine synthase ThrC | 1.96 | 2.89 | n.s. | n.s. |
| Fatty acid and lipid metabolism | |||||
| NWMN_RS06420 | Fatty acid synthesis transcriptional factor FapR | 0.63 | n.s. | 0.45 | 0.51 |
| NWMN_RS04800 | 3-oxoacyl synthase FabH | 0.56 | n.s. | 0.55 | 0.59 |
n.s., statistically not significant (P > 0.05 or |L2FC| < 0.58); -, not present in the genome.
FIG 2Differential expression of host S. aureus genes. (A) Gene ontology pathway enrichment analysis of downregulated (blue) and upregulated genes (red) in phage K-infected S. aureus Newman and SH1000 (|L2FC| < 0.58 and P < 0.05). The DE genes were involved in 8 gene ontology groups defined by ClueGO and KEGG, which are indicated with different colors. (B) Volcano plots showing DE genes of S. aureus Newman and SH1000 20 min post phage K infection compared to uninfected control. Points above the horizontal dashed line represent significantly expressed genes with P < 0.05. The total number of analyzed genes was 2815 strain Newman, and 2479 strain SH1000 and they are represented by the average L2FC values.